Healthcare Sales & Marketing Network News: IVUS

Searching News Database: IVUS

HSMN NewsFeed - 3 Mar 2025
Boston Scientific Announces Agreement to Acquire SoniVie Ltd.
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 25 Apr 2024
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
Devices FDA

HSMN NewsFeed - 9 Jan 2023
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
Devices Venture Capital

HSMN NewsFeed - 22 Sep 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
Devices

HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Jul 2019
Leading US Proton Center Selects RayStation for Treatment Planning
Devices Radiology Oncology

HSMN NewsFeed - 10 May 2019
Rani Therapeutics Hires First CFO
Devices Drug Delivery Personnel

HSMN NewsFeed - 2 May 2019
Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon
Devices Interventional Cardiology FDA

HSMN NewsFeed - 12 Feb 2018
ImmunoMet Appoints Vincent J. O'Neill, M.D., B.Sc., M.R.C.P, as Chief Medical Officer, and Allan L. Shaw as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Aug 2017
Philips and HeartFlow Announce Global Collaboration Agreement
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2017
Philips showcases new integrated image-guided therapy solutions at 2017 EuroPCR to transform cardiac care and help improve patient care
Devices Interventional Cardiology Radiology

HSMN NewsFeed - 26 Apr 2017
John Tucker appointed as Chief Executive Officer of scPharmaceuticals
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 8 Nov 2016
The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Sep 2016
Marinus Appoints Seth H.Z. Fischer to its Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Jan 2016
Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jan 2016
QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
Devices Interventional Cardiology

HSMN NewsFeed - 7 Aug 2015
Timothy E. Morris Joins PAION Inc. As A Non Executive Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Sep 2014
Volcano to Showcase Two Novel Commercial Products at TCT 2014: SyncVision(R), and the iFR(R) Modality
Devices Interventional Cardiology

HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 28 Apr 2014
Actinium Announces Key Additions to Senior Management Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 25 Apr 2014
Volcano Announces Limited Market Release of SyncVision(TM) Technology System
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 25 Mar 2014
AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2014
Targacept Appoints John P. Richard as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2013
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Biopharmaceuticals Licensing

HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology

HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Aug 2013
Infraredx Receives $25 Million Investment from Nipro Corporation
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 24 Jul 2013
Boston Scientific Launches OptiCross(TM) Coronary Imaging Catheter in U.S., Europe and Japan
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 9 Jul 2013
VIVUS Announces Avanafil Partnership With Menarini
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Jun 2013
VIVUS Announces SPEDRA (avanafil) Approval in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology

HSMN NewsFeed - 1 May 2013
New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology

HSMN NewsFeed - 3 Dec 2012
Volcano Corporation Announces Agreement To Acquire Crux Biomedical
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 26 Nov 2012
Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent
Devices Interventional Cardiology

HSMN NewsFeed - 23 Nov 2012
Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 14 Nov 2012
Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
Devices Interventional Cardiology

HSMN NewsFeed - 24 Oct 2012
Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne(R) System
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2012
STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing(R) Stent
Devices Interventional Cardiology FDA

HSMN NewsFeed - 4 Oct 2012
Volcano Announces CE Mark and 510(k) Clearance for New Visions(R) PV .035 Digital IVUS Catheter
Devices Interventional Cardiology FDA

HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Aug 2012
Elixir Medical Receives CE Mark Approval for the DESyne(R) BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 18 Jun 2012
XenoPort Appoints Ernest Mario, Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 23 May 2012
Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012
Devices Interventional Cardiology

HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2012
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY(TM) Stent Versus PROMUS Element(TM) Platinum Chromium Stent
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2012
Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
Devices Interventional Cardiology Radiology

HSMN NewsFeed - 10 May 2012
Boston Scientific Announces Schedule For EuroPCR 2012
Devices Interventional Cardiology

HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2012
VIVUS Appoints Ernest Mario, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2011
Tryton Announces DRG Reimbursement Code for Side Branch Stent in Germany
Devices Interventional Cardiology Reimbursement

HSMN NewsFeed - 7 Nov 2011
InfraReDx Announces the Launch of the TVC Imaging System(TM) for True Vessel Characterization of Coronary Artery Disease
Devices Interventional Cardiology

HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA

HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology

HSMN NewsFeed - 13 Jul 2011
InfraReDx Initiates a Randomized Clinical Trial of LipiScan IVUS™ Coronary Imaging Guidance to Prevent Heart Attacks During Stenting
Devices Interventional Cardiology

HSMN NewsFeed - 31 May 2011
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
Devices Interventional

HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
Biopharmaceuticals Urology Oncology

HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Apr 2011
InfraReDx Receives European CE Mark Approval of LipiScan(TM) IVUS Coronary Imaging System
Devices Cardiology Regulatory

HSMN NewsFeed - 4 Apr 2011
Medtronic Resolute(R) Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies
Devices Interventional Cardiology

HSMN NewsFeed - 28 Mar 2011
Pathway Medical Technologies Announces Enrollment of First Patient in JETSTREAM G3 Calcium Study
Devices Interventional

HSMN NewsFeed - 4 Mar 2011
Volcano Announces the Introduction of the Eagle Eye(R) Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 17 Feb 2011
Boston Scientific Launches PROMUS(R) Element and TAXUS(R) Element Stent Systems in India
Devices Interventional Cardiology

HSMN NewsFeed - 11 Feb 2011
Cappella Medical Announces New Sideguard(R) Clinical Data on Bifurcation Plaque Redistribution
Devices Interventional Cardiology

HSMN NewsFeed - 9 Feb 2011
InfraReDx Appoints Donald Southard as President and Chief Executive Officer
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 31 Jan 2011
Cappella Medical Devices Announces First Enrolled Patients in Italian Sideguard(R) Study
Devices Interventional Cardiology

HSMN NewsFeed - 24 Jan 2011
Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY Drug-Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 21 Jan 2011
VIVUS Provides Regulatory Update on QNEXA NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Dec 2010
Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent
Devices Interventional Cardiology

HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2010
Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent
Devices Interventional Cardiology FDA

HSMN NewsFeed - 12 Oct 2010
InfraReDx Completes $21 Million Equity Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 12 Oct 2010
Tryton Announces First Patient Enrollment in E-Tryton Italy Registry of the Tryton Side Branch Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 29 Sep 2010
Tryton Announces Positive Six-Month Results for Side Branch Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology

HSMN NewsFeed - 21 Sep 2010
Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
Devices Interventional Cardiology

HSMN NewsFeed - 17 Sep 2010
Elixir Medical Corporation Initiates Enrollment in the EXCELLA BD Randomized Clinical Trial of the Elixir Novolimus Eluting Coronary Stent System with Bioabsorbable Polymer
Devices Interventional Cardiology

HSMN NewsFeed - 1 Sep 2010
InfraReDx Receives FDA Clearance for LipiScan IVUS Coronary Imaging System
Devices Cardiology

HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
Devices Interventional Cardiology

HSMN NewsFeed - 22 Jun 2010
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 21 Jun 2010
Sosei to Acquire Activus Pharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 May 2010
Volcano Introduces VIBE RX - the World's Only Vascular Imaging Balloon Catheter
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology

HSMN NewsFeed - 25 May 2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex Balloon Catheter
Devices FDA Interventional Cardiology Regulatory

HSMN NewsFeed - 24 May 2010
Boston Scientific Announces Collaborations on Cardiovascular Imaging Technology With Philips and Siemens
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2010
Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire PRESTIGE(TM) Pressure Guide Wire
Devices Interventional Cardiology FDA

HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Apr 2010
Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 26 Mar 2010
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2010
Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Devices Interventional Monitoring

HSMN NewsFeed - 1 Mar 2010
Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions

HSMN NewsFeed - 9 Feb 2010
Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Devices Interventional FDA

HSMN NewsFeed - 9 Feb 2010
FlowCardia, Inc. Initiates CENTRAL Study Enrollment
Devices Interventional

HSMN NewsFeed - 11 Jan 2010
VIVUS Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes
Biopharmaceuticals

HSMN NewsFeed - 29 Dec 2009
VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Devices Interventional Cardiology

HSMN NewsFeed - 23 Nov 2009
Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Nov 2009
Cappella, Inc. Announces Initiation of Sideguard 3
Devices Interventional Cardiology

HSMN NewsFeed - 3 Nov 2009
VIVUS Announces Promotion of Peter Tam to President
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology

HSMN NewsFeed - 24 Sep 2009
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Devices Cardiology

HSMN NewsFeed - 23 Sep 2009
Elixir Medical Corporation Announces Positive First-In-Man Results for Three Drug Eluting Coronary Stent Systems with Durable and Bioabsorbable Polymers
Devices Interventional Cardiology

HSMN NewsFeed - 22 Sep 2009
Stentys Discloses Results for World's First Clinical Study to Treat Acute Myocardial Infarction (AMI) with a Self-Expanding Stent
Devices Interventional Cardiology

HSMN NewsFeed - 25 Aug 2009
Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS/FFR Systems
Devices Interventional Cardiology

HSMN NewsFeed - 8 Jul 2009
Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
Devices Interventional Distribution

HSMN NewsFeed - 1 Jun 2009
vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2009
First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2009
Boston Scientific Announces Schedule for EuroPCR 2009
Devices Interventional Cardiology

HSMN NewsFeed - 7 May 2009
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Biopharmaceuticals

HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 19 Mar 2009
Boston Scientific Launches New Coronary Imaging Catheter
Devices Interventional Cardiology

HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 12 Mar 2009
Acute myocardial infarction (AMI) successfully treated with Stentys self-expanding platform, solving stent-malapposition
Devices Interventional Cardiology

HSMN NewsFeed - 28 Jan 2009
VIVUS Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jan 2009
Volcano Highlights Commitment, Market Acceptance of FFR Product Line
Devices Interventional Cardiology

HSMN NewsFeed - 23 Dec 2008
Volcano Announces Acquisition of Axsun Technologies, Inc.
Devices Acquisitions

HSMN NewsFeed - 16 Oct 2008
Elixir Medical Corporation Announced Positive First-In-Man Results from Three Drug Eluting Coronary Stent Systems
Devices Interventional Cardiology

HSMN NewsFeed - 15 Oct 2008
Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
Devices Interventional Cardiology

HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 13 Oct 2008
GE Healthcare and Boston Scientific Collaborate on Cardiovascular Imaging
Devices Cardiology Radiology

HSMN NewsFeed - 13 Oct 2008
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels
Devices Interventional Cardiology

HSMN NewsFeed - 6 Oct 2008
Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
Devices

HSMN NewsFeed - 15 Sep 2008
Volcano Announces Resignation of Olav Bergheim from Board of Directors
Devices Interventional Personnel

HSMN NewsFeed - 15 Sep 2008
MIV Therapeutics VESTAsync(TM) Drug-Eluting Stent Trials Progress
Devices Interventional Cardiology

HSMN NewsFeed - 2 Sep 2008
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Devices Cardiology

HSMN NewsFeed - 5 Aug 2008
MIV Announces Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2008
Volcano Announces Acquisition of Novelis, Inc.
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology

HSMN NewsFeed - 8 May 2008
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
Devices Cardiology

HSMN NewsFeed - 5 May 2008
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Devices Interventional

HSMN NewsFeed - 21 Apr 2008
VIVUS Appoints Charles J. Casamento to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2008
VIVUS Enters into $30 Million Funding Collaboration for the Phase 3 Studies of Avanafil for Erectile Dysfunction
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 31 Mar 2008
First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 31 Mar 2008
MIV Preliminary Nine-Month Human Data Affirms Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 28 Mar 2008
Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
Devices Interventional Cardiology

HSMN NewsFeed - 7 Feb 2008
Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
Devices FDA Interventional Cardiology

HSMN NewsFeed - 21 Jan 2008
Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Devices Interventional Cardiology

HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Dec 2007
Volcano Announces Closing of CardioSpectra Acquisition
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 12 Dec 2007
VIVUS Initiates Third Qnexa Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2007
Volcano Announces Agreement to Acquire CardioSpectra
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 16 Nov 2007
VIVUS Initiates Second Qnexa Pivotal Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2007
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Nov 2007
Cleveland Clinic Study Suggests Failure of HDL-Raising Drug Torcetrapib is Likely Compound Specific
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Oct 2007
Spectranetics Announces Clinical Data From Cello Trial
Devices Interventional

HSMN NewsFeed - 22 Oct 2007
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 22 Oct 2007
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
Devices Interventional Cardiology

HSMN NewsFeed - 16 Oct 2007
Results of First-In-Man Study With MIVT Low Dose Polymer-Free Drug-Eluting Stent to Be Presented at TCT Conference
Devices Interventional Cardiology

HSMN NewsFeed - 2 Aug 2007
Volcano Corporation Announces Japan Approval of the Revolution(R) 45 MHz High-Frequency Rotational IVUS Imaging Catheter and System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 30 Jul 2007
VIVUS Receives FDA Approval of Evamist NDA
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 23 Jul 2007
Volcano Corporation Announces Japan Approval of the s5i Integrated IVUS Platform
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 6 Jul 2007
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 5 Jul 2007
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 21 Jun 2007
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
Biopharmaceuticals

HSMN NewsFeed - 14 Jun 2007
Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir) capsules in Diverse Group of Highly Treatment-Experienced HIV Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 29 May 2007
PSS World Medical to Acquire Activus Healthcare Solutions
Devices Distribution Mergers & Acquisitions

HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology

HSMN NewsFeed - 22 May 2007
Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 16 May 2007
VIVUS Closes EvaMist Transaction with KV Pharmaceutical
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 15 May 2007
Boston Scientific Announces Schedule for EuroPcr 2007
Devices Interventional Cardiology

HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
Devices Interventional Cardiology

HSMN NewsFeed - 4 Apr 2007
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique
Devices Interventional Cardiology

HSMN NewsFeed - 3 Apr 2007
ev3 Inc. and Volcano Corporation Announce Joint Marketing and Distribution Agreement
Devices Interventional Distribution

HSMN NewsFeed - 2 Apr 2007
GE Healthcare and Volcano Corporation Enable the World's Only Fully Integrated IVUS System
Devices Interventional Cardiology

HSMN NewsFeed - 30 Mar 2007
KV Pharmaceutical Company Acquires U.S. Rights to EvaMist(TM) - A Novel New Product for the Treatment of the Symptoms of Menopause
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 30 Mar 2007
VIVUS Agrees to Sell EvaMist Rights to KV Pharmaceutical
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Mar 2007
Philips and Volcano Corporation to Collaborate to Strengthen Cardiovascular Imaging Systems
Devices Cardiology

HSMN NewsFeed - 26 Mar 2007
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 26 Mar 2007
Volcano Corporation Announces Launch of Touchpad IVUS Controller, ACC Presence
Devices Interventional Cardiology

HSMN NewsFeed - 25 Mar 2007
GE Healthcare Re-imagining Cardiology at ACC07
Devices Cardiology Radiology

HSMN NewsFeed - 24 Mar 2007
Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 21 Mar 2007
Boston Scientific iLab(TM) System Hits Record Sales
Devices Interventional Cardiology

HSMN NewsFeed - 13 Feb 2007
Volcano Corporation Announces Distribution Agreement for Peripheral and Endovascular IVUS Indications in Japan
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 6 Feb 2007
Optivus Widens Industry Experience with New Vice President of Sales
Devices Oncology Personnel

HSMN NewsFeed - 12 Dec 2006
VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2006
Volcano Corporation Announces Collaboration With Stanford University, Cardialysis and Cardiovascular Research Foundation Core Labs to Facilitate In-Depth IVUS Studies of Drug Eluting Stent Safety and Performance
Devices Interventional Cardiology

HSMN NewsFeed - 6 Dec 2006
New Bifurcation Stent System Provides Breakthrough in Treatment of Ostial-Bifurcated Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 29 Nov 2006
Urigen N.A., Inc. Appoints Terry M. Nida to Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2006
Volcano Announces Clinical Review of Key Presentations From TCT 2006
Devices Interventional Cardiology

HSMN NewsFeed - 1 Nov 2006
Panacos Appoints Scott McCallister, M.D., Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2006
VIVUS Appoints Changjin (CJ) Wang, Ph.D. as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Devices Interventional Cardiology

HSMN NewsFeed - 24 Oct 2006
Abbott Reports Initial Results From World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2006
Vital Images and Toshiba Medical Systems Corporation Launch SUREPlaque(TM) Coronary Plaque Characterization Software
Devices Radiology Cardiology

HSMN NewsFeed - 21 Oct 2006
Volcano Corporation Announces Schedule of Events for TCT 2006
Devices Interventional Cardiology

HSMN NewsFeed - 20 Oct 2006
Volcano Corporation and MediGuide Ltd. Announce Collaboration for Advanced Imaging and Navigation Technology
Devices Interventional Cardiology

HSMN NewsFeed - 19 Oct 2006
GE Healthcare and Volcano Corporation Announce World's First Installation of Innova IVUS and Plans to Enable All Future U.S. Innova Labs to Be IVUS Ready
Devices Radiology Cardiology

HSMN NewsFeed - 17 Oct 2006
Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006
Devices Interventional Cardiology

HSMN NewsFeed - 11 Oct 2006
Volcano Announces First Permanent Installations of the Integrated s5i IVUS Imaging System
Devices Interventional Cardiology

HSMN NewsFeed - 14 Jul 2006
Boston Scientific's iLab(TM) Ultrasound Imaging System Makes it Easier to View Within the Heart and Vessels
Devices Interventional

HSMN NewsFeed - 27 Jun 2006
Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 1 Jun 2006
Lipid Sciences, Inc. Initiates Human Clinical Trial of Plasma Delipidation System
Devices Cardiology

HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2006
Abbott Announces First Patients Enrolled in ZOMAXX(TM) EUROPE Clinical Trial
Devices Interventional Cardiology

HSMN NewsFeed - 11 May 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Devices Interventional Cardiology

HSMN NewsFeed - 10 May 2006
VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, a Novel Therapy to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 9 May 2006
Boston Scientific to Release Latest Clinical Trial Results on Market-Leading TAXUS(R) Coronary Stent Systems at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 5 May 2006
VIVUS Announces Positive Phase 3 Clinical Trial Results for Evamist(TM) - The First Transdermal Spray for the Treatment of Menopausal Symptoms
Biopharmaceuticals Drug Delivery

Return to NewsFeed

Additional items found! 98

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 98 additional stories matching:
IVUS
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.